10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

þ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

for the quarterly period ended September 30, 2010 or

o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

for the transition period from                     to                    

Commission file number 0-20488

Psychiatric Solutions, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Delaware
(State or Other Jurisdiction of Incorporation or
Organization) 23-2491707
(I.R.S. Employer Identification No.)

6640 Carothers Parkway, Suite 500
Franklin, TN 37067
(Address of Principal Executive Offices, Including Zip Code)

(615) 312-5700
(Registrant’s Telephone Number, Including Area Code)

     Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. þ Yes o No

     Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). þ Yes o No

     Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer þ	Accelerated filer o	Non-accelerated filer o	Smaller Reporting Company o
		(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). o Yes þ No

As of November 4, 2010, 57,284,703 shares of the registrant’s common stock were outstanding.

TABLE OF CONTENTS

	PAGE
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
Condensed Consolidated Balance Sheets as of September 30, 2010 and December 31, 2009 (Unaudited)		1
Condensed Consolidated Statements of Income for the three and nine month periods ended September 30, 2010 and 2009 (Unaudited)		2
Condensed Consolidated Statements of Cash Flows for the nine month periods ended September 30, 2010 and 2009 (Unaudited)		3
Notes to Condensed Consolidated Financial Statements (Unaudited)		4
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		17
Item 3. Quantitative and Qualitative Disclosures About Market Risk		25
Item 4. Controls and Procedures		26
PART II. OTHER INFORMATION
Item 1. Legal Proceedings		26
Item 1A. Risk Factors		27
Item 6. Exhibits		27
EX-31.1
EX-31.2
EX-32.1

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

PSYCHIATRIC SOLUTIONS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited, in thousands)

	September 30,		December 31,
	2010		2009
ASSETS
Current assets:
Cash and cash equivalents	$	43,422	$	6,815
Accounts receivable, less allowance for doubtful accounts of $53,710 and $51,894, respectively		258,822		249,439
Other current assets		94,155		105,166
Total current assets		396,399		361,420
Property and equipment, net of accumulated depreciation		977,250		931,730
Cost in excess of net assets acquired		1,153,111		1,153,111
Other assets		57,009		60,979
Total assets	$	2,583,769	$	2,507,240
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	35,709	$	35,397
Salaries and benefits payable		97,930		81,129
Other accrued liabilities		91,871		62,036
Current portion of long-term debt		4,436		4,940
Total current liabilities		229,946		183,502
Long-term debt, less current portion		1,075,182		1,182,139
Deferred tax liability		81,786		81,137
Other liabilities		31,097		25,790
Total liabilities		1,418,011		1,472,568
Redeemable noncontrolling interests		4,583		4,337
Stockholders’ equity:
Common stock, $0.01 par value, 125,000 shares authorized; 57,287 and 56,226 issued and outstanding, respectively		573		562
Additional paid-in capital		642,087		627,476
Retained earnings		518,515		402,297
Total stockholders’ equity		1,161,175		1,030,335
Total liabilities and stockholders’ equity	$	2,583,769	$	2,507,240

See accompanying notes.

1

PSYCHIATRIC SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited, in thousands, except for per share amounts)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2010			2009			2010			2009
Revenue	$	508,544		$	453,187		$	1,487,194		$	1,342,404
Salaries, wages and employee benefits (including share-based compensation of $4,946, $4,249, $12,738 and $13,525 for the respective three and nine month periods in 2010 and 2009)		256,713			252,617			779,486			746,807
Professional fees		46,921			42,040			142,567			124,332
Supplies		24,350			23,137			72,332			69,549
Rentals and leases		4,893			5,040			14,571			15,169
Other operating expenses		50,216			44,600			157,427			126,687
Provision for doubtful accounts		8,615			9,817			30,552			26,569
Depreciation and amortization		12,968			11,436			38,237			32,904
Interest expense		16,663			18,551			49,714			53,263
		421,339			407,238			1,284,886			1,195,280
Income from continuing operations before income taxes		87,205			45,949			202,308			147,124
Provision for income taxes		33,277			17,651			77,572			56,380
Income from continuing operations		53,928			28,298			124,736			90,744
Loss from discontinued operations, net of income tax benefit of $433, $279, $4,466 and $581 for the respective three and nine month periods of 2010 and 2009		(796	)		(153	)		(8,221	)		(464	)
Net income		53,132			28,145			116,515			90,280
Less: Net income attributable to noncontrolling interests		(247	)		7			(297	)		(338	)
Net income attributable to PSI stockholders	$	52,885		$	28,152		$	116,218		$	89,942
Basic earnings per share:
Income from continuing operations attributable to PSI stockholders	$	0.96		$	0.51		$	2.23		$	1.63
Loss from discontinued operations, net of taxes		(0.01	)		—			(0.15	)		(0.01	)
Net income attributable to PSI stockholders	$	0.95		$	0.51		$	2.08		$	1.62
Diluted earnings per share:
Income from continuing operations attributable to PSI stockholders	$	0.94		$	0.50		$	2.19		$	1.61
Loss from discontinued operations, net of taxes		(0.02	)		—			(0.15	)		(0.01	)
Net income attributable to PSI stockholders	$	0.92		$	0.50		$	2.04		$	1.60
Shares used in computing per share amounts:
Basic		55,945			55,579			55,850			55,545
Diluted		57,356			56,340			56,913			56,077
Amounts attributable to PSI stockholders:
Income from continuing operations	$	53,681		$	28,305		$	124,439		$	90,406
Loss from discontinued operations, net of taxes		(796	)		(153	)		(8,221	)		(464	)
Net income	$	52,885		$	28,152		$	116,218		$	89,942

See accompanying notes.

2

PSYCHIATRIC SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, in thousands)

	Nine Months Ended September 30,
	2010			2009
Operating activities:
Net income	$	116,515		$	90,280
Adjustments to reconcile net income to net cash provided by continuing operating activities:
Depreciation and amortization		38,237			32,904
Amortization of loan costs and bond discount/premium		4,728			3,574
Share-based compensation		12,738			13,525
Change in income tax assets and liabilities		45,472			15,624
Loss from discontinued operations, net of taxes		8,221			464
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable		(9,383	)		(4,611	)
Other current assets		(7,527	)		771
Accounts payable		3,606			(1,707	)
Salaries and benefits payable		16,801			3,421
Accrued liabilities and other liabilities		(5,364	)		995
Net cash provided by continuing operating activities		224,044			155,240
Net cash provided by (used in) discontinued operating activities		1,189			(252	)
Net cash provided by operating activities		225,233			154,988
Investing activities:
Cash paid for acquisitions, net of cash acquired		—			(32,708	)
Cash paid for real estate acquisitions		—			(18,996	)
Capital purchases of leasehold improvements, equipment and software		(82,371	)		(95,392	)
Other assets		35			389
Net cash used in continuing investing activities		(82,336	)		(146,707	)
Net cash used in discontinued investing activities		(12	)		(221	)
Net cash used in investing activities		(82,348	)		(146,928	)
Financing activities:
Net decrease in revolving credit facility		—			(138,374	)
Borrowings on long-term debt		—			106,500
Principal payments on long-term debt		(109,176	)		(3,823	)
Payment of loan and issuance costs		(27	)		(9,826	)
Excess tax benefit from share-based payment arrangements		—			208
Distributions to noncontrolling interests		(51	)		(723	)
Repurchase of common stock upon restricted stock vesting		(490	)		(992	)
Proceeds from exercises of common stock options		3,466			1,065
Net cash used in financing activities		(106,278	)		(45,965	)
Net increase (decrease) in cash		36,607			(37,905	)
Cash and cash equivalents at beginning of the period		6,815			51,271
Cash and cash equivalents at end of the period	$	43,422		$	13,366

See accompanying notes.

3

PSYCHIATRIC SOLUTIONS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
SEPTEMBER 30, 2010

1. Recent Developments

On May 16, 2010, we entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Universal Health Services, Inc., a Delaware corporation (“UHS”), and Olympus Acquisition Corp., a Delaware corporation and a wholly-owned subsidiary of UHS (“Merger Sub”). Under the terms of the Merger Agreement, Merger Sub will be merged with and into us, with us continuing as the surviving corporation and as a wholly-owned subsidiary of UHS (the “Merger”). On October 5, 2010, our stockholders adopted the Merger Agreement at a special meeting of stockholders.

At the effective time of the Merger, each outstanding share of our common stock (the “Common Stock”), other than shares held in our treasury or owned by UHS or Merger Sub, will be cancelled and converted into the right to receive $33.75 in cash, without interest (the “Merger Consideration”), or an aggregate of approximately $2.0 billion. Including the assumption of approximately $1.1 billion in net debt, the total transaction consideration is approximately $3.1 billion.

We made customary representations, warranties and covenants in the Merger Agreement. We are subject to a “no-shop” restriction on our ability to solicit third-party proposals, provide information and engage in discussions with third parties.

The Merger Agreement contains termination rights and provides that, upon the termination of the Merger Agreement, under specified circumstances, we will be required to reimburse UHS for its transaction expenses and that, under specified circumstances, we will be required to pay UHS a termination fee of $71.5 million.

The parties to the Merger Agreement are entitled to specific performance of the terms and provisions of the Merger Agreement, in addition to any other remedy to which they are entitled, including damages for any breach of the Merger Agreement by the other party. Consummation of the Merger is not subject to a financing condition, but is subject to various other conditions, including expiration or termination of applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR Act”) and other customary closing conditions. On July 28, 2010, we and UHS each received a Request for Additional Information (“Second Request”) from the Federal Trade Commission (“FTC”) in connection with their filings under the HSR Act. Both we and UHS have complied with the Second Request and anticipate FTC approval of the transaction in November 2010. The parties also expect to close the transaction in November 2010. Where this Quarterly Report on Form 10-Q discusses our future plans, strategies or activities, such discussion does not give effect to the proposed Merger.

2. Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for audited financial statements. The condensed consolidated balance sheet at December 31, 2009 has been derived from the audited financial statements as of that date, but does not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation of our financial position have been included. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates. The majority of our expenses are “cost of revenue” items. Costs that could be classified as general and administrative expenses at our corporate office, excluding share-based compensation expense, were approximately 3.0% of net revenue for the nine months ended September 30, 2010, which includes approximately $8.8 million in

4

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
SEPTEMBER 30, 2010

costs related to our agreement to be acquired by UHS. Operating results for the three and nine months ended September 30, 2010 are not necessarily indicative of the results that may be expected for the year ending December 31, 2010. For further information, refer to the financial statements and footnotes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2009.

3. Earnings Per Share

GAAP requires dual presentation of basic and diluted earnings per share by entities with complex capital structures. Basic earnings per share includes no dilution and is computed by dividing net income available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share also includes the potential dilution of securities that could share in our earnings. We have calculated earnings per share accordingly for all periods presented.

The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share amounts):

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2010			2009			2010			2009
Numerator:
Basic and diluted earnings per share:
Income from continuing operations attributable to PSI stockholders	$	53,681		$	28,305		$	124,439		$	90,406
Loss from discontinued operations, net of taxes		(796	)		(153	)		(8,221	)		(464	)
Net income attributable to PSI stockholders	$	52,885		$	28,152		$	116,218		$	89,942
Denominator:
Weighted average shares outstanding for basic earnings per share		55,945			55,579			55,850			55,545
Effects of dilutive stock options and restriced stock outstanding		1,411			761			1,063			532
Shares used in computing diluted earnings per common share		57,356			56,340			56,913			56,077
Basic earnings per share:
Income from continuing operations attributable to PSI stockholders	$	0.96		$	0.51		$	2.23		$	1.63
Loss from discontinued operations, net of taxes		(0.01	)		—			(0.15	)		(0.01	)
Net income attributable to PSI stockholders	$	0.95		$	0.51		$	2.08		$	1.62
Diluted earnings per share:
Income from continuing operations attributable to PSI stockholders	$	0.94		$	0.50		$	2.19		$	1.61
Loss from discontinued operations, net of taxes		(0.02	)		—			(0.15	)		(0.01	)
Net income attributable to PSI stockholders	$	0.92		$	0.50		$	2.04		$	1.60

4. Share-Based Compensation

We recognized $4.9 million and $4.2 million in share-based compensation expense for the three months ended September 30, 2010 and 2009, respectively, and approximately $1.9 million and $1.6 million of related income tax benefit in each period. We recognized $12.7 million and $13.5 million in share-based compensation expense and approximately $4.9 million and $5.2 million of related income tax benefit for the nine months ended September 30, 2010 and 2009, respectively. The fair value of our stock options was estimated using the Black-Scholes option pricing model. The impact of share-based compensation expense, net of tax, on our earnings per share was approximately $0.05 per share for each of the three month periods ended September 30, 2010 and 2009. The impact of share-based compensation expense, net of tax, on our earnings per share was approximately $0.14 and $0.15 per share for the nine months ended September 30, 2010 and 2009, respectively.

Based on our stock option and restricted stock grants outstanding at September 30, 2010, we estimate remaining unrecognized share-based compensation expense to be approximately $38.9 million with a weighted average remaining life of 2.6 years.

Employees and non-employee members of our Board of Directors exercised 178,381 stock options during the nine months ended September 30, 2010. Also during 2010, 189,799 shares of restricted stock vested and 22,399 of those shares were surrendered by our employees and cancelled in satisfaction of the employees’ related tax liabilities. The total intrinsic value, which represents the difference between the underlying stock’s market price and the share-based award’s exercise price, of options exercised and restricted stock vested during the nine months ended September 30, 2010 and 2009 was approximately $6.0 million and $4.8 million,

5

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
SEPTEMBER 30, 2010

respectively.

We granted 842,750 stock options to employees during the nine months ended September 30, 2010. These options vest over four years in annual increments of 25% on each anniversary of the grant date and each had a grant-date fair value of $7.92.

We granted 917,200 shares of restricted stock to employees and non-employee members of our Board of Directors during the nine months ended September 30, 2010. These shares of restricted stock vest over four years in annual increments of 25% on each anniversary of the grant date and had a weighted-average grant-date fair value of $21.24 per share.

5. Acquisitions

On September 1, 2009, we completed the acquisition of a 131-bed inpatient behavioral health care facility located in Fargo, North Dakota. On September 30, 2009, we completed the acquisition of a 90-bed inpatient behavioral health care facility located in Panama City, Florida.

The balance of cost in excess of net assets acquired (goodwill) was approximately $1.2 billion as of September 30, 2010 and December 31, 2009.

6. Long-term debt

Long-term debt consists of the following (in thousands):

	September 30,		December 31,
	2010		2009
Senior credit facility:
Senior secured term loan facility, expiring on July 1, 2012 and bearing interest of 2.2% and 2.0% at September 30, 2010 and December 31, 2009, respectively	$	456,748	$	564,875
7 3/4% Senior Subordinated Notes due 2015		583,385		582,666
Mortgage loans on facilities, maturing in 2036, 2037 and 2038 bearing fixed interest rates of 5.7% to 7.6%		32,516		32,850
Other		6,969		6,688
		1,079,618		1,187,079
Less current portion		4,436		4,940
Long-term debt	$	1,075,182	$	1,182,139

Senior Credit Facility

Our Senior Credit Facility (the “Credit Agreement”) includes a $300 million revolving line of credit facility administered by Bank of America, N.A. and a $575 million senior secured term loan facility administered by Citicorp North America, Inc. During 2009, our revolving credit facility was amended to extend the maturity to December 31, 2011. Quarterly principal payments of $0.8 million are due on our senior secured term loan facility and the balance of our senior secured term loan facility is payable in full on July 1, 2012.

Our Credit Agreement is secured by substantially all of the personal property owned by us or our subsidiaries, substantially all real property owned by us or our subsidiaries that has a value in excess of $5.0 million and the stock of substantially all of our operating subsidiaries. In addition, the Credit Agreement is fully and unconditionally guaranteed by substantially all of our operating subsidiaries. The revolving credit facility and senior secured term loan facility accrue interest at our choice of the “Base Rate” or the “Eurodollar Rate” (as defined in the Credit Agreement). The “Base Rate” and “Eurodollar Rate” fluctuate based upon market rates and certain leverage ratios, as defined in the Credit Agreement. At September 30, 2010, we had no borrowings outstanding and $296.0 million available for future borrowings under the revolving credit facility. Until December 31, 2011, we may borrow, repay and re-borrow an amount not to exceed $300 million on our revolving credit facility. On June 30, 2010 and September 30, 2010, we made $50.0 million optional repayments under the senior secured term loan facility. All repayments made under the senior secured term loan facility are a permanent reduction in the amount available for future borrowings. We pay a quarterly commitment fee on the unused portion of our revolving credit facility that fluctuates, based upon certain leverage ratios, between 0.75% and 1.0% per annum. Commitment fees were approximately $1.7 million for the nine months ended September 30, 2010.

Our Credit Agreement contains customary covenants that include: (1) a limitation on capital expenditures and investments, sales of assets, mergers, changes of ownership, new principal lines of business, indebtedness, transactions with affiliates, dividends and

6

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
SEPTEMBER 30, 2010

redemptions; (2) various financial covenants; and (3) cross-default covenants triggered by a default of any other indebtedness of at least $5.0 million. As of September 30, 2010, we were in compliance with all debt covenant requirements. If we violate one or more of these covenants, amounts outstanding under the revolving credit facility, senior secured term loan facility and the majority of our other debt arrangements could become immediately payable and additional borrowings could be restricted.

7³/₄% Notes

The 7³/₄% Senior Subordinated Notes due 2015 (the “7³/₄% Notes”) mature on July 15, 2015 and are fully and unconditionally guaranteed on a senior subordinated basis by substantially all of our existing operating subsidiaries. In May 2009, we issued $120 million of the 7³/₄% Notes at a discount of 11.25%. This discount is being amortized over the remaining life of the 7³/₄% Notes using the effective interest rate method, which results in an effective interest rate of 10.2% per annum on the $120 million issuance. We received a premium of 2.75% plus accrued interest from the sale of $250 million of 7³/₄% Notes in 2007. This premium is being amortized over the remaining life of the 7³/₄% Notes using the effective interest method, which results in an effective interest rate of 7.3% on the $250 million issuance. We also issued $220 million of the 7³/₄% Notes in 2005. Interest on the 7³/₄% Notes is payable semi-annually in arrears on January 15 and July 15.

Mortgage Loans

At September 30, 2010, we had approximately $32.5 million debt outstanding under mortgage loan agreements insured by the U.S. Department of Housing and Urban Development (“HUD”). The mortgage loans insured by HUD are secured by real estate located at Holly Hill Hospital in Raleigh, North Carolina, West Oaks Hospital in Houston, Texas, Riveredge Hospital near Chicago, Illinois, Canyon Ridge Hospital in Chino, California and MeadowWood Behavioral Health in New Castle, Delaware. Interest accrues on the Holly Hill, West Oaks, Riveredge, Canyon Ridge and MeadowWood HUD loans at 6.0%, 5.9%, 5.7%, 7.6% and 7.0%, respectively, and principal and interest are payable in 420 monthly installments through December 2037, September 2038, December 2038, January 2036 and October 2036, respectively. The carrying amount of assets held as collateral for the HUD loans approximated $59.4 million at September 30, 2010.

7. Income Taxes

The provision for income taxes for continuing operations for the nine months ended September 30, 2010 and 2009 reflects an effective tax rate of approximately 38.4%.

8. Discontinued Operations

GAAP requires that all components of an entity that have been disposed of (by sale, by abandonment or in a distribution to owners) or are held for sale and whose cash flows can be clearly distinguished from the rest of the entity be presented as discontinued operations. During 2009, we sold our EAP business, elected to close and sell Nashville Rehabilitation Hospital, The Oaks Treatment Center and Cumberland Hall of Chattanooga, and terminated one contract with a South Carolina juvenile justice agency. With the exception of our EAP business that was reported in our other segment, the results of these operations were reported in our owned and leased facilities segment prior to the decision to discontinue.

The components of loss from discontinued operations, net of taxes, are as follows (in thousands):

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2010			2009			2010			2009
Revenue	$	—		$	17,417		$	2,446		$	54,127
Operating expenses		1,229			17,745			8,892			55,069
Loss on disposal		—			104			6,241			103
		1,229			17,849			15,133			55,172
Loss from discontinued operations before income taxes		(1,229	)		(432	)		(12,687	)		(1,045	)
Income tax benefit		(433	)		(279	)		(4,466	)		(581	)
Loss from discontinued operations, net of income taxes	$	(796	)	$	(153	)	$	(8,221	)	$	(464	)

7

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
SEPTEMBER 30, 2010

9. Disclosures About Reportable Segments

In accordance with GAAP, our owned and leased behavioral health care facilities segment is our only reportable segment. Our chief operating decision maker regularly reviews the operating results of our inpatient facilities on a combined basis, which represent more than 90% of our consolidated revenue. As of September 30, 2010, the owned and leased facilities segment provides mental health and behavioral health services to patients in its 85 owned and 8 leased inpatient facilities in 32 states, Puerto Rico and the U.S. Virgin Islands. The column entitled “Other” in the schedules below includes management contracts to provide inpatient psychiatric management and development services to inpatient behavioral health units in hospitals and clinics and a managed care plan in Puerto Rico. The operations included in the “Other” column do not qualify as reportable segments. Activities classified as “Corporate” in the following schedules relate primarily to unallocated home office expenses and discontinued operations. In the second quarter of 2010 we recognized approximately $12.1 million in revenue received by our Mississippi facilities from the Medicare/Medicaid Upper Payment Limits (“UPL”) Program relating to services provided during the twelve months ended June 30, 2010. The additional UPL Program revenue was partially offset by additional taxes of approximately $7.0 million paid under the Mississippi Hospital Assessment Program in the second quarter of 2010. In the third quarter of 2010 we recognized approximately $13 million of revenue from various Medicare/Medicaid UPL Programs, federal government stimulus funds, disproportionate share payments, settlements and other programs.

Adjusted EBITDA is a non-GAAP financial measure and is defined as income from continuing operations before interest expense (net of interest income), income taxes, depreciation, amortization, share-based compensation and other items included in the caption labeled “Other expenses.” These other expenses may occur in future periods, but the amounts recognized can vary significantly from period to period and do not directly relate to the ongoing operations of our health care facilities. Our management relies on adjusted EBITDA as the primary measure to review and assess the operating performance of our inpatient facilities and their management teams. We believe it is useful to investors to provide disclosures of our operating results on the same basis as that used by management. Management and investors also review adjusted EBITDA to evaluate our overall performance and to compare our current operating results with corresponding periods and with other companies in the health care industry. You should not consider adjusted EBITDA in isolation or as a substitute for net income, operating cash flows or other cash flow statement data determined in accordance with GAAP. Because adjusted EBITDA is not a measure of financial performance under GAAP and is susceptible to varying calculations, it may not be comparable to similarly titled measures of other companies. The following is a financial summary by reportable segment for the periods indicated (dollars in thousands):

Three Months Ended September 30, 2010

	Owned and
	Leased
	Facilities		Other		Corporate			Consolidated
Revenue	$	471,391	$	37,153	$	—		$	508,544
Adjusted EBITDA	$	127,802	$	6,341	$	(12,608	)	$	121,535
Interest expense		7,180		86		9,397			16,663
Provision for income taxes		—		—		33,277			33,277
Depreciation and amortization		11,542		1,026		400			12,968
Inter-segment expenses		13,475		1,209		(14,684	)		—
Other expenses:
Share-based compensation		—		—		4,946			4,946
Total other expenses		—		—		4,946			4,946
Income (loss) from continuing operations attributable to PSI stockholders	$	95,605	$	4,020	$	(45,944	)	$	53,681
Total assets	$	2,410,617	$	57,635	$	115,517		$	2,583,769

8

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
SEPTEMBER 30, 2010

Three Months Ended September 30, 2009

	Owned and
	Leased
	Facilities		Other		Corporate			Consolidated
Revenue	$	420,421	$	32,766	$	—		$	453,187
Adjusted EBITDA	$	87,058	$	2,856	$	(9,722	)	$	80,192
Interest expense		7,082		79		11,390			18,551
Provision for income taxes		—		—		17,651			17,651
Depreciation and amortization		10,015		1,014		407			11,436
Inter-segment expenses		12,903		1,182		(14,085	)		—
Other expenses:
Share-based compensation		—		—		4,249			4,249
Total other expenses		—		—		4,249			4,249
Income (loss) from continuing operations attributable to PSI stockholders	$	57,058	$	581	$	(29,334	)	$	28,305
Total assets	$	2,322,967	$	60,185	$	188,973		$	2,572,125

Nine Months Ended September 30, 2010

	Owned and
	Leased
	Facilities		Other		Corporate			Consolidated
Revenue	$	1,381,279	$	105,915	$	—		$	1,487,194
Adjusted EBITDA	$	334,866	$	12,625	$	(44,791	)	$	302,700
Interest expense		21,544		246		27,924			49,714
Provision for income taxes		—		—		77,572			77,572
Depreciation and amortization		33,880		3,114		1,243			38,237
Inter-segment expenses		40,455		3,593		(44,048	)		—
Other expenses:
Share-based compensation		—		—		12,738			12,738
Total other expenses		—		—		12,738			12,738
Income (loss) from continuing operations attributable to PSI stockholders	$	238,987	$	5,672	$	(120,220	)	$	124,439
Total assets	$	2,410,617	$	57,635	$	115,517		$	2,583,769

9

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
SEPTEMBER 30, 2010

Nine Months Ended September 30, 2009

	Owned and
	Leased
	Facilities		Other			Corporate			Consolidated
Revenue	$	1,248,314	$	94,090		$	—		$	1,342,404
Adjusted EBITDA	$	268,333	$	11,897		$	(33,752	)	$	246,478
Interest expense		21,316		(866	)		32,813			53,263
Provision for income taxes		—		(1,229	)		57,609			56,380
Depreciation and amortization		28,444		3,260			1,200			32,904
Inter-segment expenses		44,564		3,994			(48,558	)		—
Other expenses:
Share-based compensation		—		—			13,525			13,525
Total other expenses		—		—			13,525			13,525
Income (loss) from continuing operations attributable to PSI stockholders	$	174,009	$	6,738		$	(90,341	)	$	90,406
Total assets	$	2,322,967	$	60,185		$	188,973		$	2,572,125

10. Financial Information for the Company and Its Subsidiaries

We conduct substantially all of our business through our subsidiaries. Presented below is consolidated financial information for Psychiatric Solutions, Inc. and its subsidiaries as of September 30, 2010 and December 31, 2009, and for the three and nine months ended September 30, 2010 and 2009. The information segregates the parent company (Psychiatric Solutions, Inc.), the combined wholly-owned subsidiary guarantors, the combined non-guarantors and eliminations. All of the subsidiary guarantees are both full and unconditional and joint and several.

Condensed Consolidating Balance Sheet
As of September 30, 2010
(Dollars in thousands)

			Combined
			Subsidiary			Combined Non-			Consolidating			Total Consolidated
	Parent		Guarantors			Guarantors			Adjustments			Amounts
Current assets:
Cash and cash equivalents	$	—	$	23,763		$	19,659		$	—		$	43,422
Accounts receivable, net		—		251,230			7,661			(69	)		258,822
Other current assets		—		92,127			7,218			(5,190	)		94,155
Total current assets		—		367,120			34,538			(5,259	)		396,399
Property and equipment, net of accumulated depreciation		—		924,697			61,535			(8,982	)		977,250
Cost in excess of net assets acquired		—		1,153,111			—			—			1,153,111
Investment in subsidiaries		1,346,469		(221,606	)		(15,904	)		(1,108,959	)		—
Other assets		13,567		37,782			25,324			(19,664	)		57,009
Total assets	$	1,360,036	$	2,261,104		$	105,493		$	(1,142,864	)	$	2,583,769
Current liabilities:
Accounts payable	$	—	$	34,699		$	1,079		$	(69	)	$	35,709
Salaries and benefits payable		—		96,569			1,361			—			97,930
Other accrued liabilities		17,668		73,005			6,974			(5,776	)		91,871
Current portion of long-term debt		3,965		—			471			—			4,436
Total current liabilities		21,633		204,273			9,885			(5,845	)		229,946
Long-term debt, less current portion		1,043,137		—			32,045			—			1,075,182
Deferred tax liability		—		81,786			—			—			81,786
Other liabilities		2,022		1,351			36,441			(8,717	)		31,097
Total liabilities		1,066,792		287,410			78,371			(14,562	)		1,418,011
Redeemable noncontrolling interests		—		4,583			—			—			4,583
Total stockholders’ equity		293,244		1,969,111			27,122			(1,128,302	)		1,161,175
Total liabilities and stockholders’ equity	$	1,360,036	$	2,261,104		$	105,493		$	(1,142,864	)	$	2,583,769

10

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
SEPTEMBER 30, 2010

Condensed Consolidating Balance Sheet
As of December 31, 2009
(Dollars in thousands)

			Combined
			Subsidiary			Combined Non-			Consolidating			Total Consolidated
	Parent		Guarantors			Guarantors			Adjustments			Amounts
Current assets:
Cash and cash equivalents	$	—	$	2,111		$	4,704		$	—		$	6,815
Accounts receivable, net		—		241,211			8,296			(68	)		249,439
Other current assets		—		90,259			16,284			(1,377	)		105,166
Total current assets		—		333,581			29,284			(1,445	)		361,420
Property and equipment, net of accumulated depreciation		—		879,453			61,491			(9,214	)		931,730
Cost in excess of net assets acquired		—		1,153,111			—			—			1,153,111
Investment in subsidiaries		1,486,852		(368,332	)		(16,964	)		(1,101,556	)		—
Other assets		17,536		37,420			25,372			(19,349	)		60,979
Total assets	$	1,504,388	$	2,035,233		$	99,183		$	(1,131,564	)	$	2,507,240
Current liabilities:
Accounts payable	$	—	$	34,467		$	998		$	(68	)	$	35,397
Salaries and benefits payable		—		80,255			874			—			81,129
Other accrued liabilities		28,901		32,783			1,610			(1,258	)		62,036
Current portion of long-term debt		4,490		—			450			—			4,940
Total current liabilities		33,391		147,505			3,932			(1,326	)		183,502
Long-term debt, less current portion		1,149,738		—			32,401			—			1,182,139
Deferred tax liability		—		81,137			—			—			81,137
Other liabilities		127		(6,324	)		36,069			(4,082	)		25,790
Total liabilities		1,183,256		222,318			72,402			(5,408	)		1,472,568
Redeemable noncontrolling interests		—		—			—			4,337			4,337
Total stockholders’ equity		321,132		1,812,915			26,781			(1,130,493	)		1,030,335
Total liabilities and stockholders’ equity	$	1,504,388	$	2,035,233		$	99,183		$	(1,131,564	)	$	2,507,240

Condensed Consolidating Statement of Income
For the Three Months Ended September 30, 2010
(Dollars in thousands)

				Combined
				Subsidiary			Combined Non-		Consolidating			Total Consolidated
	Parent			Guarantors			Guarantors		Adjustments			Amounts
Revenue	$	—		$	497,060		$	12,921	$	(1,437	)	$	508,544
Salaries, wages and employee benefits		—			250,576			6,137		—			256,713
Professional fees		—			45,787			1,536		(402	)		46,921
Supplies		—			23,780			570		—			24,350
Rentals and leases		—			5,956			152		(1,215	)		4,893
Other operating expenses		—			49,158			1,393		(335	)		50,216
Provision for doubtful accounts		—			8,141			474		—			8,615
Depreciation and amortization		—			12,435			610		(77	)		12,968
Interest expense		16,206			—			482		(25	)		16,663
		16,206			395,833			11,354		(2,054	)		421,339
(Loss) income from continuing operations before income taxes		(16,206	)		101,227			1,567		617			87,205
(Benefit from) provision for income taxes		(6,184	)		38,628			598		235			33,277
(Loss) income from continuing operations		(10,022	)		62,599			969		382			53,928
(Loss) income from discontinued operations, net of tax		—			(796	)		—		—			(796	)
Net (loss) income		(10,022	)		61,803			969		382			53,132
Less: Net income attributable to noncontrolling interests		—			—			—		(247	)		(247	)
Net (loss) income attributable to PSI stockholders	$	(10,022	)	$	61,803		$	969	$	135		$	52,885

11

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
SEPTEMBER 30, 2010

Condensed Consolidating Statement of Income
For the Three Months Ended September 30, 2009

(Dollars in thousands)

				Combined
				Subsidiary			Combined Non-		Consolidating			Total Consolidated
	Parent			Guarantors			Guarantors		Adjustments			Amounts
Revenue	$	—		$	442,718		$	15,302	$	(4,833	)	$	453,187
Salaries, wages and employee benefits		—			245,768			6,849		—			252,617
Professional fees		—			40,921			1,157		(38	)		42,040
Supplies		—			22,572			565		—			23,137
Rentals and leases		—			6,059			64		(1,083	)		5,040
Other operating expenses		—			43,696			3,892		(2,988	)		44,600
Provision for doubtful accounts		—			9,482			335		—			9,817
Depreciation and amortization		—			10,947			566		(77	)		11,436
Interest expense		18,100			—			451		—			18,551
		18,100			379,445			13,879		(4,186	)		407,238
(Loss) income from continuing operations before income taxes		(18,100	)		63,273			1,423		(647	)		45,949
(Benefit from) provision for income taxes		(6,953	)		24,306			547		(249	)		17,651
(Loss) income from continuing operations		(11,147	)		38,967			876		(398	)		28,298
(Loss) income from discontinued operations, net of tax		—			(404	)		251		—			(153	)
Net (loss) income		(11,147	)		38,563			1,127		(398	)		28,145
Less: Net income attributable to noncontrolling interests		—			—			—		7			7
Net (loss) income attributable to PSI stockholders	$	(11,147	)	$	38,563		$	1,127	$	(391	)	$	28,152

Condensed Consolidating Statement of Income
For the Nine Months Ended September 30, 2010
(Dollars in thousands)

				Combined
				Subsidiary			Combined Non-		Consolidating			Total Consolidated
	Parent			Guarantors			Guarantors		Adjustments			Amounts
Revenue	$	—		$	1,453,399		$	40,793	$	(6,998	)	$	1,487,194
Salaries, wages and employee benefits		—			760,230			19,256		—			779,486
Professional fees		—			138,940			5,007		(1,380	)		142,567
Supplies		—			70,456			1,876		—			72,332
Rentals and leases		—			17,725			445		(3,599	)		14,571
Other operating expenses		—			154,155			9,069		(5,797	)		157,427
Provision for doubtful accounts		—			29,312			1,240		—			30,552
Depreciation and amortization		—			36,574			1,895		(232	)		38,237
Interest expense		48,287			—			1,452		(25	)		49,714
		48,287			1,207,392			40,240		(11,033	)		1,284,886
(Loss) income from continuing operations before income taxes		(48,287	)		246,007			553		4,035			202,308
(Benefit from) provision for income taxes		(18,515	)		94,328			212		1,547			77,572
(Loss) income from continuing operations		(29,772	)		151,679			341		2,488			124,736
(Loss) income from discontinued operations, net of tax		—			(8,221	)		—		—			(8,221	)
Net (loss) income		(29,772	)		143,458			341		2,488			116,515
Less: Net income attributable to noncontrolling interests		—			—			—		(297	)		(297	)
Net (loss) income attributable to PSI stockholders	$	(29,772	)	$	143,458		$	341	$	2,191		$	116,218

12

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
SEPTEMBER 30, 2010

Condensed Consolidating Statement of Income
For the Nine Months Ended September 30, 2009
(Dollars in thousands)

				Combined
				Subsidiary			Combined Non-		Consolidating			Total Consolidated
	Parent			Guarantors			Guarantors		Adjustments			Amounts
Revenue	$	—		$	1,311,110		$	40,358	$	(9,064	)	$	1,342,404
Salaries, wages and employee benefits		—			727,159			19,648		—			746,807
Professional fees		—			121,390			5,943		(3,001	)		124,332
Supplies		—			67,811			1,738		—			69,549
Rentals and leases		—			18,257			112		(3,200	)		15,169
Other operating expenses		—			123,866			7,971		(5,150	)		126,687
Provision for doubtful accounts		—			25,786			783		—			26,569
Depreciation and amortization		—			31,489			1,647		(232	)		32,904
Interest expense		51,963			—			1,300		—			53,263
		51,963			1,115,758			39,142		(11,583	)		1,195,280
(Loss) income from continuing operations before income taxes		(51,963	)		195,352			1,216		2,519			147,124
(Benefit from) provision for income taxes		(19,913	)		74,862			466		965			56,380
(Loss) income from continuing operations		(32,050	)		120,490			750		1,554			90,744
(Loss) income from discontinued operations, net of tax		—			(1,271	)		807		—			(464	)
Net (loss) income		(32,050	)		119,219			1,557		1,554			90,280
Less: Net income attributable to noncontrolling interests		—			—			—		(338	)		(338	)
Net (loss) income attributable to PSI stockholders	$	(32,050	)	$	119,219		$	1,557	$	1,216		$	89,942

13

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
SEPTEMBER 30, 2010

Condensed Consolidating Statement of Cash Flows
For the Nine Months Ended September 30, 2010
(Dollars in thousands)

				Combined
				Subsidiary			Combined Non-			Consolidating			Total Consolidated
	Parent			Guarantors			Guarantors			Adjustments			Amounts
Operating activities:
Net (loss) income	$	(29,772	)	$	143,458		$	341		$	2,488		$	116,515
Adjustments to reconcile net (loss) income to net
cash (used in) provided by operating activities:
Depreciation and amortization		—			36,574			1,895			(232	)		38,237
Amortization of loan costs and bond premium		4,694			—			34			—			4,728
Share-based compensation		—			12,738			—			—			12,738
Change in income tax assets and liabilities		—			45,472			—			—			45,472
Loss from discontinued operations, net of taxes		—			8,221			—						8,221
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable		—			(10,018	)		635			—			(9,383	)
Other current assets		—			(16,593	)		9,066			—			(7,527	)
Accounts payable		—			3,525			81			—			3,606
Salaries and benefits payable		—			16,314			487			—			16,801
Accrued liabilities and other liabilities		—			(11,100	)		5,736			—			(5,364	)
Net cash (used in) provided by continuing operating activities		(25,078	)		228,591			18,275			2,256			224,044
Net cash provided by discontinued operating activities		—			1,189			—			—			1,189
Net cash (used in) provided by operating activities		(25,078	)		229,780			18,275			2,256			225,233
Investing activities:
Capital purchases of leasehold improvements, equipment and software		—			(80,431	)		(1,940	)		—			(82,371	)
Other assets		—			3,418			(3,383	)		—			35
Net cash used in continuing investing activities		—			(77,013	)		(5,323	)		—			(82,336	)
Net cash used in discontinued investing activities		—			(12	)		—			—			(12	)
Net cash used in investing activities		—			(77,025	)		(5,323	)		—			(82,348	)
Financing activities:
Principal payments on long-term debt		(108,840	)		—			(336	)		—			(109,176	)
Payment of loan and issuance costs		(27	)		—			—			—			(27	)
Distributions to noncontrolling interests		(51	)		—			—			—			(51	)
Repurchase of common stock upon restricted stock vesting		(490	)		—			—			—			(490	)
Net transfers to and from members		131,020			(131,103	)		2,339			(2,256	)		—
Proceeds from exercises of common stock options		3,466			—			—			—			3,466
Net cash provided by (used in) financing activities		25,078			(131,103	)		2,003			(2,256	)		(106,278	)
Net increase in cash and cash equivalents		—			21,652			14,955			—			36,607
Cash and cash equivalents at beginning of the period		—			2,111			4,704			—			6,815
Cash and cash equivalents at end of the period	$	—		$	23,763		$	19,659		$	—		$	43,422

14

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
SEPTEMBER 30, 2010

Condensed Consolidating Statement of Cash Flows
For the Nine Months Ended September 30, 2009
(Dollars in thousands)

				Combined
				Subsidiary			Combined Non-			Consolidating			Total Consolidated
	Parent			Guarantors			Guarantors			Adjustments			Amounts
Operating activities:
Net (loss) income	$	(32,050	)	$	119,219		$	1,557		$	1,554		$	90,280
Adjustments to reconcile net (loss) income to net
cash (used in) provided by operating activities:
Depreciation and amortization		—			31,489			1,647			(232	)		32,904
Amortization of loan costs and bond premium		3,540			—			34			—			3,574
Share-based compensation		—			13,525			—			—			13,525
Change in income tax assets and liabilities		—			15,624			—			—			15,624
Loss from discontinued operations, net of taxes		—			464			—						464
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable		—			(4,132	)		(479	)		—			(4,611	)
Other current assets		—			4,334			(3,563	)		—			771
Accounts payable		—			(1,857	)		150			—			(1,707	)
Salaries and benefits payable		—			3,599			(178	)		—			3,421
Accrued liabilities and other liabilities		—			(5,742	)		6,737			—			995
Net cash (used in) provided by continuing operating activities		(28,510	)		176,523			5,905			1,322			155,240
Net cash provided by discontinued operating activities		—			(252	)		—			—			(252	)
Net cash (used in) provided by operating activities		(28,510	)		176,271			5,905			1,322			154,988
Investing activities:
Cash paid for acquisitions, net of cash acquired		(32,708	)		—			—			—			(32,708	)
Cash paid for real estate acquisitions		—			(18,996	)		—			—			(18,996	)
Capital purchases of leasehold improvements, equipment and software		—			(89,643	)		(5,749	)		—			(95,392	)
Other assets		—			3,615			(3,226	)		—			389
Net cash used in continuing investing activities		(32,708	)		(105,024	)		(8,975	)		—			(146,707	)
Net cash used in discontinued investing activities		—			(221	)		—			—			(221	)
Net cash used in investing activities		(32,708	)		(105,245	)		(8,975	)		—			(146,928	)
Financing activities:
Net increase in revolving credit facility, less acquisitions		(138,374	)		—			—			—			(138,374	)
Borrowings on long-term debt		106,500			—			—			—			106,500
Principal payments on long-term debt		(3,509	)		—			(314	)		—			(3,823	)
Payment of loan and issuance costs		(9,826	)		—			—			—			(9,826	)
Excess tax benefits from share-based payment arrangements		208			—			—			—			208
Distributions to noncontrolling interests		(723	)		—			—			—			(723	)
Repurchase of common stock upon restricted stock vesting		(992	)		—			—			—			(992	)
Net transfers to and from members		106,869			(107,106	)		1,559			(1,322	)		—
Proceeds from exercises of common stock options		1,065			—			—			—			1,065
Net cash provided by (used in) financing activities		61,218			(107,106	)		1,245			(1,322	)		(45,965	)
Net decrease in cash and cash equivalents		—			(36,080	)		(1,825	)		—			(37,905	)
Cash and cash equivalents at beginning of the period		—			39,881			11,390			—			51,271
Cash and cash equivalents at end of the period	$	—		$	3,801		$	9,565		$	—		$	13,366

11. Contingencies and Other

We are, from time to time, subject to various claims and legal actions that arise in the ordinary course of our business, including claims for damages for personal injuries, medical malpractice, breach of contract, business tort and employment related claims. In these actions, plaintiffs request a variety of damages, including, in some instances, punitive and other types of damages that may not be covered by insurance.

In October 2010, we received a subpoena from the United States Department of Justice requesting certain documents regarding one of our inpatient facilities in Philadelphia, Pennsylvania. We intend to provide the requested documents to the Department of Justice.

In the opinion of management, we are not currently a party to any proceeding that would have a material adverse effect on our business, financial condition or results of operations.

The reserve for professional and general liability increased to $23.5 million as of September 30, 2010 from $19.0 million as of December 31, 2009, which is primarily due to new and existing claim developments in 2010.

Litigation Related to the Merger

Seven putative class action complaints were filed on behalf of alleged public stockholders of the Company. Two of the lawsuits, Carpenters Pension Fund of West Virginia v. Psychiatric Solutions, Inc., et al., Case No. 38359, and Pedric v. Psychiatric Solutions, Inc., et al., Case No. 38391, were filed in the Chancery Court for Williamson County, Tennessee. One of the lawsuits, Smith v. Psychiatric Solutions, Inc., et al., Case No. 10-862-II, was filed in the Chancery Court for Davidson County, Tennessee. The Smith case was transferred to Williamson County. Another three lawsuits, Oklahoma Police Pension and Retirement System v. Jacobs, et al.,

15

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
SEPTEMBER 30, 2010

Case No. CA 5514, City of Miami Police Relief and Pension Fund v. Jacobs, et al., Case No. 5515, and Plumbers & Pipefitters, Local 152 Pension Fund v. Psychiatric Solutions, Inc., et al., Case No. 5532, were filed in the Court of Chancery for the State of Delaware. A seventh lawsuit, Rosinek v. Psychiatric Solutions, Inc., et al., Case No. 3:10-cv-00534, was filed in the United States District Court for the Middle District of Tennessee. The defendants generally include us, members of our board of directors and, in certain of the cases, our officers. UHS and/or its affiliates are named as defendants in some of the lawsuits. The lawsuits allege, among other things, that our directors breached their fiduciary duties in connection with the proposed Merger by failing to maximize stockholder value. The lawsuits also allege that our directors have put their personal interests ahead of those of our stockholders, including by approving the Merger to extinguish any personal liability they could suffer from previously asserted derivative claims related to, among other things, violations of fiduciary duties and federal securities laws and also by negotiating a Merger Agreement that includes broad director and officer insurance and indemnification provisions protecting them against civil and criminal claims for six years from the date of the Merger Agreement. Certain of the lawsuits allege that various individual defendants will receive improper change of control payments and Merger Consideration in connection with equity awards that plaintiffs contend were improper. Certain of the lawsuits also allege that we and UHS aided and abetted the various breaches of fiduciary duty. Certain of the lawsuits also allege that various individual defendants caused us to issue a proxy statement containing materially false and misleading statements and omissions in connection with our 2010 annual stockholder meeting. Among other things, the lawsuits seek to enjoin us and our directors from consummating the Merger and also seek rescission of the allegedly improper equity awards. The three Delaware cases were consolidated and set for trial beginning on August 5, 2010. The three Tennessee state court cases were consolidated in Williamson County, and then stayed in favor of the consolidated Delaware action by agreed order of the Williamson County court.

After substantially completing fact discovery in the consolidated Delaware action, without admitting liability on the part of any of the defendants, the parties to the consolidated Delaware action and the consolidated Tennessee state court action have agreed in principle to terms of settlement as follows: (1) requiring additional disclosures in the proxy statement delivered to stockholders in connection with the Special Meeting called to vote on the Merger regarding, among other things, the background of and negotiations relating to the Merger, the Executive Performance Incentive Plan, the amendment to our 2009 Long-Term Equity Compensation Plan and adoption of the 2010 Long-Term Equity Compensation Plan, the circumstances surrounding our compensation committee’s approval of equity and restricted stock grants in February 2010, and the financial disclosures relating to the transaction, including the discounted cash flow and other analyses performed by Goldman Sachs & Co.; (2) allowing our stockholders to revote on the proposal to amend the Psychiatric Solutions, Inc. Equity Incentive Plan (the “Equity Incentive Plan”) to increase the number of shares of Common Stock subject to grant under the Equity Incentive Plan by 900,000 and to restrict the repricing of options, originally approved by our stockholders at our annual meeting of stockholders in May 2010, and which revote was held on October 5, 2010, with stockholders again approving the amendment to the Equity Incentive Plan; (3) requiring the release by the class of stockholders entitled to vote on the Merger of any and all claims that have been or could have been made against any of the defendants relating to the Merger, the disclosures made by or on behalf of us through and including consummation of the Merger, and the compensation received by any defendant through and including the consummation of the Merger; and (4) requiring us to pay plaintiffs’ reasonable attorneys’ fees and expenses in the amounts ordered by the courts. The settlements in those actions are subject to court approval, which has not yet been obtained.

The parties to the Rosinek case have agreed in principal to settle that case on terms identical to the proposed settlement in the consolidated cases, with the additional promise from the Rosinek plaintiff that she will participate in and not object to the class certification necessary in the consolidated cases for the court to approve the settlement. The United States District Court has stayed the Rosinek case in light of the parties proposed settlement and in favor of the settlement approval proceedings in the consolidated cases.

The settlements in the consolidated and Rosinek cases will not affect the form or amount of the consideration to be received by our stockholders in the Merger. The defendants have denied and continue to deny any wrongdoing or liability with respect to all claims, events, and transactions complained of in the aforementioned lawsuits or that they have engaged in any wrongdoing. The defendants have entered into the settlements to eliminate the uncertainty, burden, risk, expense and distraction of further litigation.

Other Litigation

A stockholder lawsuit and a stockholder derivative lawsuit alleging violations of federal securities laws were filed in 2009 against us and certain of our executives. We believe that the lawsuits are without merit and are defending them vigorously. The stockholder derivative lawsuit will be extinguished by the closing of the Merger.

16

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward-Looking Statements

     This Quarterly Report on Form 10-Q and other materials we have filed or may file with the Securities and Exchange Commission (the “SEC”), as well as information included in oral statements or other written statements made, or to be made, by our senior management, contain, or will contain, disclosures that are forward-looking statements. Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as “may,” “will,” “expect,” “believe,” “intend,” “plan,” “estimate,” “project,” “continue,” “should” and other comparable terms. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of known and unknown risks, uncertainties and other factors, including those set forth below, which could significantly affect our current plans and expectations and future financial condition and results.

     We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Stockholders and investors are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in our filings and reports.

     While it is not possible to identify all these factors, we continue to face many risks and uncertainties that could cause actual results to differ from those forward-looking statements, including:

• the occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement;

• the outcome of any legal proceedings that have been or may be instituted against us and others relating to the Merger Agreement or other matters;

• the inability to complete the Merger due to the failure to satisfy conditions to consummation of the merger, including the expiration or termination of any waiting period applicable to the consummation of the Merger under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended;

• the failure of UHS to obtain the necessary debt financing to consummate the Merger;

• the failure of the Merger to close for any other reason;

• risks that the proposed Merger disrupts current plans and operations and the potential difficulties in employee retention as a result of the Merger;

• the effect of the pending Merger on our physician and patient relationships, operating results and business generally;

• the amount of the costs, fees, expenses and charges related to the Merger and the actual terms of the debt financing that will be obtained for the Merger;

• the Merger Agreement restricts our ability to take certain actions without UHS’ approval, including making acquisitions, dispositions, investments or capital expenditures and entering into or amending material contracts;

• risks inherent to the health care industry, including the impact of unforeseen changes in regulation and the potential adverse impact of government investigations, liabilities and other claims asserted against us;

• uncertainty as to changes in U.S. general economic activity and the impact of these changes on our business;

• economic downturn resulting in efforts by federal and state health care programs and managed care companies to reduce reimbursement rates for our services;

• implementation and effect of newly-adopted federal health care legislation and potential state health care legislation;

• our ability to comply with applicable licensure and accreditation requirements;

• our ability to comply with extensive laws and government regulations related to billing, physician relationships, adequacy of medical care and licensure;

• our ability to successfully integrate and improve the operations of acquired inpatient facilities;

• our ability to maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act;

• potential competition that alters or impedes our acquisition strategy by decreasing our ability to acquire additional inpatient facilities on favorable terms;

17

• our substantial indebtedness and adverse changes in credit markets impacting our ability to receive timely additional financing on terms acceptable to us to fund our acquisition strategy and capital expenditure needs;

• our ability to maintain favorable and continuing relationships with physicians and other health care professionals who use our inpatient facilities;

• our ability to ensure confidential information is not inappropriately disclosed and that we are in compliance with federal and state health information privacy standards;

• our ability to comply with federal and state governmental regulation covering health care-related products and services on-line, including the regulation of medical devices and the practice of medicine and pharmacology;

• our ability to obtain adequate levels of general and professional liability insurance;

• future trends for pricing, margins, revenue and profitability that remain difficult to predict in the industries that we serve;

• fluctuations in the market value of our common stock, including fluctuations resulting from announcements by us of significant corporate events;

• negative press coverage of us or our industry that may affect public opinion; and

• those risks and uncertainties described from time to time in our filings with the SEC.

     We caution you that the factors listed above, as well as the risk factors included in our Annual Report on Form 10-K for the year ended December 31, 2009 and Quarterly Reports on Forms 10-Q for the quarters ended March 31, 2010 and June 30, 2010, may not be exhaustive. We operate in a continually changing business environment, and new risk factors emerge from time to time. We cannot predict such new risk factors nor can we assess the impact, if any, of such new risk factors on our businesses or the extent to which any factor or combination of factors may cause actual results to differ materially from those expressed or implied by any forward-looking statements.

Overview

     Our business strategy is to acquire inpatient behavioral health care facilities and improve operating results within our inpatient facilities and our other behavioral health care operations. From 2001 to 2006, we acquired 74 inpatient behavioral health care facilities. During 2007, we acquired 16 inpatient behavioral health care facilities, including 15 inpatient facilities in the acquisition of Horizon Health Corporation. During 2008, we acquired five inpatient behavioral health care facilities from United Medical Corporation and opened Lincoln Prairie Behavioral Health Center, an 80-bed inpatient facility in Springfield, Illinois. During 2009, we opened Rolling Hills Hospital, an 80-bed inpatient facility in Franklin, Tennessee, acquired two inpatient behavioral health care facilities, and completed the sale of our EAP business.

     We strive to improve the operating results of our inpatient behavioral health care operations by providing the highest quality service, expanding referral networks and marketing initiatives and meeting increased demand for behavioral health care services by expanding our services and developing new services. We also attempt to improve operating results by maintaining appropriate staffing ratios, controlling contract labor costs and reducing supply costs through group purchasing.

     Income from continuing operations before income taxes increased to $87.2 million and $202.3 million, or 17.1% and 13.6% of revenue, for the three and nine months ended September 30, 2010, respectively, compared to $45.9 million and $147.1 million, or 10.1% and 11.0% of revenue, for the same periods of 2009, respectively, primarily as a result of a 12.1% and 10.7% increase in revenue from owned and leased inpatient facilities, respectively. Our same-facility revenue from owned and leased inpatient facilities increased 10.4% and 8.4% for the three and nine months ended September 30, 2010, respectively, compared to the same periods in 2009, primarily as a result of increases in patient days of 4.0% and 4.7% and revenue per patient day of 6.1% and 3.4%, respectively. The increase in revenue per patient day was positively impacted by approximately $13 million of revenue in the third quarter of 2010 resulting from various Medicare/Medicaid Upper Payment Limit (“UPL”) programs, federal government stimulus funds, disproportionate share payments, settlements and other programs as well as approximately $12.1 million received by our Mississippi facilities in the second quarter of 2010 from the Medicare/Medicaid UPL Program relating to services provided during the twelve months ended June 30, 2010. The additional UPL Program revenue was partially offset by additional taxes of approximately $7.0 million paid under the Mississippi Hospital Assessment Program in the second quarter of 2010. Same-facility operating margins improved for the three and nine months ended September 30, 2010 compared to the same periods of 2009, primarily due to the increase in revenue and a decrease in salaries, wages and employee benefits expense as a percent of revenue to 48.9% and 50.7% from 54.6% and 53.9%, respectively. Operating margins were negatively affected by $2.4 million and $8.8 million of transaction fees incurred as a result of the proposed Merger for the three and nine months ended September 30, 2010, respectively. Same-facility growth refers to the comparison of each inpatient facility owned during 2009 with the comparable period in 2010, adjusted for closures and combinations for comparability purposes.

18

Proposed Merger

     On May 16, 2010, we entered into the Merger Agreement with UHS and Merger Sub, a Delaware corporation and a wholly-owned subsidiary of UHS. Under the terms of the Merger Agreement, Merger Sub will be merged with and into us, with us continuing as the surviving corporation and as a wholly-owned subsidiary of UHS. On October 5, 2010, our stockholders adopted the Merger Agreement at a special meeting of stockholders.

     At the effective time of the Merger, each outstanding share of our Common Stock, other than shares held in our treasury or owned by UHS or Merger Sub, will be cancelled and converted into the right to receive $33.75 in cash, without interest, or an aggregate of approximately $2.0 billion. Including the assumption or repayment of approximately $1.1 billion in net debt, the total transaction consideration is approximately $3.1 billion.

     We made customary representations, warranties and covenants in the Merger Agreement. We are subject to a “no-shop” restriction on our ability to solicit third-party proposals, provide information and engage in discussions with third parties.

     The Merger Agreement contains termination rights and provides that, upon the termination of the Merger Agreement, under specified circumstances, we will be required to reimburse UHS for its transaction expenses and that, under specified circumstances, we will be required to pay UHS a termination fee of $71.5 million.

     The parties to the Merger Agreement are entitled to specific performance of the terms and provisions of the Merger Agreement, in addition to any other remedy to which they are entitled, including damages for any breach of the Merger Agreement by the other party. Consummation of the Merger is not subject to a financing condition, but is subject to various other conditions, including expiration or termination of applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR Act”) and other customary closing conditions. On July 28, 2010, we and UHS each received a Request for Additional Information (“Second Request”) from the Federal Trade Commission (“FTC”) in connection with their filings under the HSR Act. Both we and UHS have complied with the Second Request and anticipate FTC approval of the transaction in November 2010. The parties also expect to close the transaction in November 2010. Where this Quarterly Report on Form 10-Q discusses our future plans, strategies or activities, such discussion does not give effect to the proposed Merger.

     We incurred transaction costs of approximately $2.4 million and $8.8 million related to the proposed Merger for the three and nine months ended September 30, 2010, respectively.

Sources of Revenue

Patient Service Revenue

     Patient service revenue is generated by our inpatient facilities for services provided to patients on an inpatient and outpatient basis within the inpatient behavioral health care facility setting. Patient service revenue is recorded at our established billing rates less contractual adjustments. Contractual adjustments are recorded to state our patient service revenue at the amount we expect to collect for the services provided based on amounts reimbursable by Medicare or Medicaid under provisions of cost or prospective reimbursement formulas or amounts due from other third-party payors at contractually determined rates. Patient service revenue comprised approximately 92.9% and 93.0% of our total revenue for the nine months ended September 30, 2010 and 2009, respectively.

Other Revenue

     Other behavioral health care services accounted for 7.1% and 7.0% of our revenue for the nine months ended September 30, 2010 and 2009, respectively. This portion of our business primarily consists of our contract management business and a managed care plan in Puerto Rico. Our contract management business involves the development, organization and management of behavioral health and rehabilitation programs within medical/surgical hospitals. Services provided are recorded as revenue at contractually determined rates in the period the services are rendered, provided that collectability of such amounts is reasonably assured.

19

Results of Operations

     The following table illustrates our consolidated results of operations from continuing operations for the three and nine months ended September 30, 2010 and 2009 (dollars in thousands):

	For the Three Months Ended September 30,											For the Nine Months Ended September 30 ,
	2010						2009					2010						2009
	Amount			%			Amount		%			Amount			%			Amount			%
Revenue	$	508,544			100.0	%	$	453,187		100.0	%	$	1,487,194			100.0	%	$	1,342,404			100.0	%
Salaries, wages, and employee benefits (including share- based compensation of $4,946, $4,249, $12,738, and $13,525 for the respective three and six month periods in 2010 and 2009)		256,713			50.5	%		252,617		55.7	%		779,486			52.4	%		746,807			55.6	%
Professional fees		46,921			9.2	%		42,040		9.3	%		142,567			9.6	%		124,332			9.2	%
Supplies		24,350			4.8	%		23,137		5.1	%		72,332			4.9	%		69,549			5.2	%
Provision for doubtful accounts		8,615			1.7	%		9,817		2.2	%		30,552			2.1	%		26,569			2.0	%
Other operating expenses		55,109			10.8	%		49,640		11.0	%		171,998			11.5	%		141,856			10.6	%
Depreciation and amortization		12,968			2.6	%		11,436		2.5	%		38,237			2.6	%		32,904			2.4	%
Interest expense, net		16,663			3.3	%		18,551		4.1	%		49,714			3.3	%		53,263			4.0	%
Income from continuing operations before income taxes		87,205			17.1	%		45,949		10.1	%		202,308			13.6	%		147,124			11.0	%
Provision for income taxes		33,277			6.5	%		17,651		3.9	%		77,572			5.2	%		56,380			4.2	%
Income from continuing operations		53,928			10.6	%		28,298		6.2	%		124,736			8.4	%		90,744			6.8	%
Less : Net income attributable to noncontrolling interest		(247	)		0.0	%		7		0.0	%		( 297	)		0.0	%		(338	)		-0.1	%
Income from continuing operations attributable to PSI stockholders	$	53,681			10.6	%	$	28,305		6.2	%	$	124,439			8.4	%	$	90,406			6.7	%

Three Months Ended September 30, 2010 Compared To Three Months Ended September 30, 2009

     The following table compares key same-facility statistics and total facility statistics for the three months ended September 30, 2010 and 2009 for our owned and leased inpatient facilities:

	For the Three Months Ended September 30,				%
	2010		2009		Change
Same-facility results:
Revenue (in thousands)	$	464,021	$	420,421		10.4	%
Admissions		48,491		44,799		8.2	%
Patient days		745,759		717,089		4.0	%
Average length of stay (in days)		15.4		16.0		-3.8	%
Revenue per patient day	$	622	$	586		6.1	%
Total facility results:
Revenue (in thousands)	$	471,391	$	420,421		12.1	%
Admissions		49,573		44,799		10.7	%
Patient days		755,277		717,089		5.3	%
Average length of stay (in days)		15.2		16.0		-5.0	%
Revenue per patient day	$	624	$	586		6.5	%

     Revenue. Revenue from continuing operations increased $55.4 million, or 12.2%, to $508.5 million for the three months ended September 30, 2010 compared to the three months ended September 30, 2009. Revenue from owned and leased inpatient facilities increased $51.0 million, or 12.1%, to $471.4 million in 2010 compared to 2009. The increase in revenue from owned and leased inpatient facilities relates primarily to same-facility growth in patient days of 4.0% and revenue per patient day of 6.1%. The increase in revenue per patient day was positively impacted by approximately $13 million of revenue in the third quarter of 2010 resulting from various Medicare/Medicaid UPL programs, federal government stimulus funds, disproportionate share payments, settlements and other programs. Other revenue increased $4.4 million to $37.2 million in 2010 compared to $32.8 million in 2009, primarily as a result of an increase in covered lives in our managed care plan in Puerto Rico.

     Salaries, wages, and employee benefits. Salaries, wages and employee benefits (“SWB”) expense was $256.7 million for the three months ended September 30, 2010 compared to $252.6 million for the three months ended September 30, 2009, an increase of $4.1 million, or 1.6%. SWB expense includes $4.9 million and $4.2 million of shared-based compensation expense for the quarters ended September 30, 2010 and 2009, respectively. Based on our stock option and restricted stock grants outstanding at September 30, 2010, we estimate remaining unrecognized share-based compensation expense to be approximately $38.9 million with a weighted-average remaining amortization period of 2.6 years. Excluding share-based compensation expense, SWB expense was $251.8 million, or 49.5% of total revenue, for the three months ended September 30, 2010 compared to $248.4 million, or 54.8% of total revenue, for the three months ended September 30, 2009. SWB expense for owned and leased inpatient facilities was $231.2 million in 2010, or 49.1% of revenue. Same-facility SWB expense for owned and leased inpatient facilities was $226.7 million in 2010, or 48.9% of revenue, compared to $229.6 million in 2009, or 54.6% of revenue. This decrease in same-facility SWB expense as a percent of revenue is

20

primarily the result of an increase in revenue and effective management of staffing levels as well as a decrease in health insurance costs. SWB expense for other operations was $12.4 million in 2010 compared to $12.3 million in 2009. SWB expense for our corporate office was $13.1 million, including $4.9 million in share-based compensation, for 2010 compared to $10.7 million, including $4.2 million in shared-based compensation, for 2009.

     Professional fees. Professional fees were $46.9 million for the three months ended September 30, 2010, or 9.2% of total revenue, compared to $42.0 million for the three months ended September 30, 2009, or 9.3% of total revenue. Professional fees for owned and leased inpatient facilities were $41.1 million in 2010, or 8.7% of revenue. Same-facility professional fees for owned and leased inpatient facilities were $40.6 million in 2010, or 8.8% of revenue, compared to $37.8 million in 2009, or 9.0% of revenue. Professional fees for other operations and our corporate office increased to $5.9 million in 2010 compared to $4.3 million in 2009 primarily as a result of approximately $2.4 million of transaction fees incurred as a result of the proposed Merger.

     Supplies. Supplies expense was $24.4 million for the three months ended September 30, 2010, or 4.8% of total revenue, compared to $23.1 million for the three months ended September 30, 2009, or 5.1% of total revenue. Supplies expense for owned and leased inpatient facilities was $24.2 million in 2010, or 5.1% of revenue. Same-facility supplies expense for owned and leased inpatient facilities was $23.9 million in 2010, or 5.1% of revenue, compared to $23.0 million in 2009, or 5.5% of revenue.

     Provision for doubtful accounts. The provision for doubtful accounts was $8.6 million for the three months ended September 30, 2010, or 1.7% of total revenue, compared to $9.8 million for the three months ended September 30, 2009, or 2.2% of total revenue. The provision for doubtful accounts at owned and leased inpatient facilities comprised substantially all of our provision for doubtful accounts.

     Other operating expenses. Other operating expenses consist primarily of rent, utilities, insurance, travel and repairs and maintenance expenses. Other operating expenses were $55.1 million for the three months ended September 30, 2010, or 10.8% of total revenue, compared to $49.6 million for the three months ended September 30, 2009, or 11.0% of total revenue. Other operating expenses for owned and leased inpatient facilities were $38.2 million in 2010, or 8.1% of revenue. Same-facility other operating expenses for owned and leased inpatient facilities were $37.6 million in 2010, or 8.1% of revenue, compared to $33.2 million in 2009, or 7.9% of revenue. Other operating expenses for other operations and our corporate office increased to $17.0 million in 2010 compared to $16.4 million in 2009.

     Depreciation and amortization. Depreciation and amortization expense increased to $13.0 million for the three months ended September 30, 2010 compared to $11.4 million for the three months ended September 30, 2009, primarily as a result of depreciation on expansion projects at our inpatient facilities and the acquisition of two facilities in 2009.

     Interest expense, net. Interest expense, net of interest income, decreased to $16.7 million for the three months ended September 30, 2010 compared to $18.6 million for the three months ended September 30, 2009. This decrease in interest expense was primarily the result of a decrease in our long-term debt outstanding during the twelve months ended September 30, 2010.

     Income attributable to noncontrolling interest. We own controlling interests in two joint ventures that each own one of our inpatient behavioral health care facilities. Income attributable to noncontrolling interests represents the pro rata portion of the joint venture’s net profit belonging to the noncontrolling partners.

     Loss from discontinued operations, net of taxes. The loss from discontinued operations, net of income tax effect, was $0.8 million for the three months ended September 30, 2010 compared to $0.2 million for the three months ended September 30, 2009. During 2009, we completed the sale of our EAP business, elected to close and make The Oaks Treatment Center and Cumberland Hall of Chattanooga available for sale, and terminated one contract with a South Carolina juvenile justice agency. We also elected to close and make Nashville Rehabilitation Hospital available for sale and transferred its behavioral health services to Rolling Hills Hospital in the first quarter of 2009.

Nine Months Ended September 30, 2010 Compared To Nine Months Ended September 30, 2009

     The following table compares key same-facility statistics and total facility statistics for the nine months ended September 30, 2010 and 2009 for our owned and leased inpatient facilities:

21

	For the Nine Months Ended September 30,				%
	2010		2009		Change
Same-facility results:
Revenue (in thousands )	$	1,353,119	$	1,248,314		8.4	%
Admissions		144,482		132,881		8.7	%
Patient days		2,246,412		2,145,861		4.7	%
Average length of stay (in days)		15.5		16.1		-3.7	%
Revenue per patient day	$	602	$	582		3.4	%
Total facility results:
Revenue (in thousands )	$	1,381,279	$	1,248,314		10.7	%
Admissions		148,248		132,881		11.6	%
Patient days		2,280,722		2,145,861		6.3	%
Average length of stay (in days)		15.4		16.1		-4.3	%
Revenue per patient day	$	606	$	582		4.1	%

     Revenue. Revenue from continuing operations increased $144.8 million, or 10.8%, to $1,487.2 million for the nine months ended September 30, 2010 compared to the nine months ended September 30, 2009. Revenue from owned and leased inpatient facilities increased $133.0 million, or 10.7%, to $1,381.3 million in 2010 compared to 2009. The increase in revenue from owned and leased inpatient facilities relates primarily to same-facility growth in patient days of 4.7% and revenue per patient day of 3.4%. The increase in revenue per patient day was positively impacted by approximately $25 million of revenue from Medicare/Medicaid UPL programs, government stimulus funds, disproportionate share payments, settlements and other programs. Other revenue increased $11.8 million to $105.9 million in 2010 compared to $94.1 million in 2009, primarily as a result of an increase in covered lives in our managed care plan in Puerto Rico.

     Salaries, wages, and employee benefits. SWB expense was $779.5 million for the nine months ended September 30, 2010 compared to $746.8 million for the nine months ended September 30, 2009, an increase of $32.7 million, or 4.4%. SWB expense includes $12.7 million and $13.5 million of shared-based compensation expense for the quarters ended September 30, 2010 and 2009, respectively. Excluding share-based compensation expense, SWB expense was $766.7 million, or 51.6% of total revenue, for the nine months ended September 30, 2010 compared to $733.3 million, or 54.6% of total revenue, for the nine months ended September 30, 2009. SWB expense for owned and leased inpatient facilities was $702.6 million in 2010, or 50.9% of revenue. Same-facility SWB expense for owned and leased inpatient facilities was $686.2 million in 2010, or 50.7% of revenue, compared to $673.2 million in 2009, or 53.9% of revenue. This decrease in same-facility SWB expense as a percent of revenue is primarily the result of an increase in revenue and effective management of staffing levels as well as a decrease in health insurance costs. SWB expense for other operations was $37.4 million in 2010 compared to $35.9 million in 2009. SWB expense for our corporate office was $39.4 million, including $12.7 million in share-based compensation, for 2010 compared to $37.7 million, including $13.5 million in shared-based compensation, for 2009.

     Professional fees. Professional fees were $142.6 million for the nine months ended September 30, 2010, or 9.6% of total revenue, compared to $124.3 million for the nine months ended September 30, 2009, or 9.2% of total revenue. Professional fees for owned and leased inpatient facilities were $121.4 million in 2010, or 8.8% of revenue. Same-facility professional fees for owned and leased inpatient facilities were $119.9 million in 2010, or 8.9% of revenue, compared to $112.7 million in 2009, or 9.0% of revenue. Professional fees for other operations and our corporate office increased to $21.1 million in 2010 compared to $11.7 million in 2009 primarily as a result of approximately $8.8 million of transaction fees incurred as a result of the proposed Merger.

     Supplies. Supplies expense was $72.3 million for the nine months ended September 30, 2010, or 4.9% of total revenue, compared to $69.5 million for the nine months ended September 30, 2009, or 5.2% of total revenue. Supplies expense for owned and leased inpatient facilities was $71.9 million in 2010, or 5.2% of revenue. Same-facility supplies expense for owned and leased inpatient facilities was $70.6 million in 2010, or 5.2% of revenue, compared to $69.1 million in 2009, or 5.5% of revenue.

     Provision for doubtful accounts. The provision for doubtful accounts was $30.6 million for the nine months ended September 30, 2010, or 2.1% of total revenue, compared to $26.6 million for the nine months ended September 30, 2009, or 2.0% of total revenue. The provision for doubtful accounts at owned and leased inpatient facilities comprised substantially all of our provision for doubtful accounts.

     Other operating expenses. Other operating expenses consist primarily of rent, utilities, insurance, travel and repairs and maintenance expenses. Other operating expenses were $172.0 million for the nine months ended September 30, 2010, or 11.5% of total revenue, compared to $141.9 million for the nine months ended September 30, 2009, or 10.6% of total revenue. Other operating expenses for owned and leased inpatient facilities were $119.5 million in 2010, or 8.7% of revenue. Same-facility other operating expenses for owned and leased inpatient facilities were $117.1 million in 2010, or 8.7% of revenue, compared to $98.2 million in 2009, or 7.9% of revenue. This increase in other operating expenses as a percent of revenue is primarily a result of an increase in our self-insured professional and general liability insurance expense as a percent of revenue compared with 2009 and a provider tax assessed by the State of Mississippi’s Medicaid program. Other operating expenses for other operations and our corporate office

22

increased to $52.5 million in 2010 compared to $43.6 million in 2009 primarily as a result of additional expenses associated with an increase in covered lives in our managed care plan in Puerto Rico.

     Depreciation and amortization. Depreciation and amortization expense increased to $38.2 million for the nine months ended September 30, 2010 compared to $32.9 million for the nine months ended September 30, 2009, primarily as a result of depreciation on expansion projects at our inpatient facilities and the acquisition of two facilities in 2009.

     Interest expense, net. Interest expense, net of interest income, decreased to $49.7 million for the nine months ended September 30, 2010 compared to $53.3 million for the nine months ended September 30, 2009. This decrease in interest expense was primarily the result of a decrease in our long-term debt outstanding during the twelve months ended September 30, 2010.

     Income attributable to noncontrolling interest. We own controlling interests in two joint ventures that each own one of our inpatient behavioral health care facilities. Income attributable to noncontrolling interests represents the pro rata portion of the joint venture’s net profit belonging to the noncontrolling partners.

     Loss from discontinued operations, net of taxes. The loss from discontinued operations, net of income tax effect, was $8.2 million for the nine months ended September 30, 2010 compared to $0.5 million for the nine months ended September 30, 2009. The $8.2 million loss in 2010 includes $6.2 million in losses recognized to decrease the carrying values of discontinued operations that are held for sale. During 2009, we completed the sale of our EAP business, elected to close and make The Oaks Treatment Center and Cumberland Hall of Chattanooga available for sale, and terminated one contract with a South Carolina juvenile justice agency. We also elected to close and make Nashville Rehabilitation Hospital available for sale and transferred its behavioral health services to Rolling Hills Hospital in the first quarter of 2009.

Liquidity and Capital Resources

     We currently have $296.0 million available for borrowings under our $300 million revolving credit facility. Additionally, our cash flow from continuing operating activities was $224.0 million for the nine months ended September 30, 2010 and we had $166.5 million of working capital, including $43.4 million of cash and cash equivalents, at September 30, 2010. We believe that our cash flow from operations, availability under our revolving credit facility and working capital are sufficient to fund our known future cash requirements for operations and capital expenditures. We historically spend approximately 2% to 3% of our revenue on routine capital expenditures.

     Working capital at September 30, 2010 was $166.5 million, including cash and cash equivalents of $43.4 million, compared to working capital of $177.9 million, including cash and cash equivalents of $6.8 million, at December 31, 2009. This decrease in working capital is primarily attributable to an increase in income taxes payable of $45.9 million and an increase in accrued salaries and benefits payable of $16.8 million, offset by increases in cash of $36.6 million, accounts receivable of $9.4 million and a decrease in accrued interest expense of $11.2 million. The $36.6 million increase in cash and cash equivalents is primarily a result of cash provided by continuing operations of $224.0 million offset by cash used for capital expenditures of $82.4 million and principal payments on long-term debt of $109.2 million. The increase in accounts receivable is primarily due to an increase of 8.4% in same-facility revenue. Our consolidated day’s sales outstanding were 47 and 49 at September 30, 2010 and December 31, 2009, respectively. The decrease in accrued interest expense is primarily the result of the semi-annual payment of interest on our 7³/₄% Notes during the third quarter of 2010. The increase in accrued salaries and benefits payable is primarily the result of seven additional days of accrued salaries at September 30, 2010 compared to December 31, 2009 due to the timing of the pay dates.

     Cash provided by continuing operating activities was $224.0 million for the nine months ended September 30, 2010 compared to $155.2 million for the nine months ended September 30, 2009. The increase in cash flows from continuing operating activities was primarily the result of cash provided by improved operating results and the timing of payments of income taxes.

     Cash used by continuing investing activities was $82.3 million for the nine months ended September 30, 2010 compared to $146.7 million for the nine months ended September 30, 2009. Cash used in investing activities for the nine months ended September 30, 2010 primarily consisted of $82.4 million paid for purchases of fixed assets. Cash used for routine and expansion capital expenditures was approximately $33.9 million and $48.5 million, respectively, for the nine months ended September 30, 2010. We define expansion capital expenditures as those that increase the capacity of our facilities or otherwise enhance revenue. Routine or maintenance capital expenditures were 2.3% of our revenue for the nine months ended September 30, 2010. Cash used in investing activities for the nine months ended September 30, 2009 consisted primarily of $95.4 million paid for purchases of fixed assets, $32.7 million paid for acquisitions and $19.0 million paid for a facility that was previously leased.

     Cash used in financing activities was $106.3 million for the nine months ended September 30, 2010 compared to $46.0 million for the nine months ended September 30, 2009. Cash used in financing activities for the nine months ended September 30, 2010 consisted primarily of $109.2 million of principal payments on our long-term debt, primarily consisting of two $50.0 million voluntary pre-payments on our senior secured term loan facility. Cash used in financing activities for the nine months ended September 30, 2009 consisted primarily of $138.4 million of net payments on the balance due under our revolving credit facility, $9.8 million paid for loan and

23

issuance costs and $3.8 million principal payments on long-term debt, offset by $106.5 million received from the issuance of $120 million of our 7 3/4% Notes at a discount of 11.25%.

     We have filed a universal shelf registration statement on Form S-3 and an acquisition shelf registration statement on Form S-4. The universal shelf registration statement permits us to sell, in one or more public offerings, an indeterminate amount of our common stock, common stock warrants, preferred stock and debt securities, or any combination of such securities, at prices and on terms satisfactory to us. The acquisition shelf registration statement enables us to issue up to 5 million shares of our common stock in one or more business combination transactions, including acquisitions by us of other businesses, assets, properties or securities. To date, no securities have been issued pursuant to either registration statement. Pursuant to the Merger Agreement, our ability to issue securities without UHS’ prior written consent is restricted.

Contractual Obligations

	Payments Due by Period (in thousands)
			Less than						More than
	Total		1 year		1 -3 years		3-5 years		5 years
Long-term debt (1):
Senior secured term loan facility, expiring on July 1, 2012 and bearing interest of 2.2% at September 30, 2010	$	456,748	$	3,047	$	453,701	$	—	$	—
7 3/4% Senior Subordinated Notes due July 15, 2015		583,385		—		—		583,385		—
Mortgage loans on facilities , maturing in 2036, 2037 and 2038 bearing fixed interest rates of 5.7% to 7.6%		32,516		471		1,035		1,171		29,839
		1,072,649		3,518		454,736		584,556		29,839
Lease and other obligations		76,563		13,305		17,744		12,956		32,558
Total contractual obligations	$	1,149,212	$	16,823	$	472,480	$	597,512	$	62,397

(1) Excludes capital lease obligations and other obligations of $7.0 million, which are included in lease and other obligations.

     The fair value of our 7³/₄% Notes was approximately $610.2 million and $565.2 million as of September 30, 2010 and December 31, 2009, respectively. The fair value of our senior secured term loan facility was approximately $452.8 million and $536.6 million as of September 30, 2010 and December 31, 2009, respectively. The carrying value of our other long-term debt, including current maturities, of $39.5 million at September 30, 2010 and December 31, 2009, approximated fair value. We had $456.7 million of variable rate debt outstanding under our senior secured term loan facility as of September 30, 2010. At our September 30, 2010 borrowing level, a hypothetical 10% increase in interest rates would decrease our annual net income and cash flows by approximately $0.6 million.

Critical Accounting Policies

     Our consolidated financial statements have been prepared in accordance with GAAP. In preparing our financial statements, we are required to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses included in the financial statements. Estimates are based on historical experience and other information currently available, the results of which form the basis of such estimates. While we believe our estimation processes are reasonable, actual results could differ from our estimates. The following represent the estimates considered most critical to our operating performance and involve the most subjective and complex assumptions and assessments.

Allowance for Doubtful Accounts

     Our ability to collect outstanding patient receivables from third-party payors is critical to our operating performance and cash flows.

     The primary collection risk with regard to patient receivables lies with uninsured patient accounts or patient accounts for which primary insurance has paid, but the portion owed by the patient remains outstanding. We estimate the allowance for doubtful accounts primarily based upon the age of the accounts since the patient discharge date. We continually monitor our accounts receivable balances and utilize cash collection data to support our estimates of the provision for doubtful accounts. Significant changes in payor mix or business office operations could have a significant impact on our results of operations and cash flows.

     The primary collection risk with regard to receivables due under our inpatient management contracts is attributable to contractual disputes. We estimate the allowance for doubtful accounts for these receivables based primarily upon the specific identification of potential collection issues. As with our patient receivables, we continually monitor our accounts receivable balances and utilize cash collection data to support our estimates of the provision for doubtful accounts.

24

Allowances for Contractual Discounts

     The Medicare and Medicaid regulations are complex and various managed care contracts may include multiple reimbursement mechanisms for different types of services provided in our inpatient facilities and cost settlement provisions requiring complex calculations and assumptions subject to interpretation. We estimate the allowance for contractual discounts on a payor-specific basis by comparing our established billing rates with the amount we determine to be reimbursable given our interpretation of the applicable regulations or contract terms. Most payments are determined based on negotiated per-diem rates. While the services authorized and provided and related reimbursement are often subject to interpretation that could result in payments that differ from our estimates, these differences are deemed immaterial. Additionally, updated regulations and contract renegotiations occur frequently necessitating continual review and assessment of the estimation process by our management. We periodically compare the contractual rates on our patient accounting systems with the Medicare and Medicaid reimbursement rates or the third-party payor contract for accuracy. We also monitor the adequacy of our contractual adjustments using financial measures such as comparing cash receipts to net patient revenue adjusted for bad debt expense.

Professional and General Liability

     We are subject to medical malpractice and other lawsuits due to the nature of the services we provide. Our operations have professional and general liability insurance in umbrella form for claims in excess of $3.0 million with an insured excess limit of $75.0 million. The self-insured reserves for professional and general liability risks are estimated based on historical claims, demographic factors, industry trends, severity factors, and other actuarial assumptions calculated by an independent third-party actuary. This estimated accrual for professional and general liabilities could be significantly affected should current and future occurrences differ from historical claim trends and expectations. We have utilized our captive insurance company to manage the self-insured retention. While claims are monitored closely when estimating professional and general liability accruals, the complexity of the claims and wide range of potential outcomes often limits timely adjustments to the assumptions used in these estimates.

Income Taxes

     As part of our process for preparing our consolidated financial statements, our management is required to compute income taxes in each of the jurisdictions in which we operate. This process involves estimating the current tax benefit or expense of future deductible and taxable temporary differences. The tax effects of future deductible and taxable temporary differences are recorded as deferred tax assets and liabilities which are components of our balance sheet. Management then assesses our ability to realize the deferred tax assets based on reversals of deferred tax liabilities and, if necessary, estimates of future taxable income. A valuation allowance for deferred tax assets is established when we believe that it is more likely than not that the deferred tax asset will not be realized. Management must also assess the impact of our acquisitions on the realization of deferred tax assets subject to a valuation allowance to determine if all or a portion of the valuation allowance will be offset by reversing taxable differences or future taxable income of the acquired entity. To the extent the valuation allowance can be reversed due to the estimated future taxable income of an acquired entity, then our valuation allowance is reduced accordingly as an adjustment to income tax expense.

     GAAP requires us to make significant judgments regarding the recognition and measurement of each tax position. Changes in these judgments may materially affect the estimate of our effective tax rate and our operating results.

Share-Based Compensation

     We record share-based compensation expense for the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of such awards. We utilize the Black-Scholes option pricing model to estimate the grant-date fair value of our stock options. The Black-Scholes model includes certain variables and assumptions that require judgment, such as the expected volatility of our stock price and the expected term of our stock options. Additionally, we use judgment in the estimation of forfeitures over the vesting period of share-based awards.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

     Our interest expense is sensitive to changes in the general level of interest rates. With respect to our interest-bearing liabilities, approximately $615.9 million of our long-term debt outstanding at September 30, 2010 was subject to a weighted-average fixed interest rate of 8.0%. Our variable rate debt is comprised of our senior secured term loan facility, which had $456.7 million outstanding at September 30, 2010 and on which interest is generally payable at LIBOR plus 1.75%.

     A hypothetical 10% increase in interest rates would decrease our net income and cash flows by approximately $0.6 million on an annual basis based upon our borrowing level at September 30, 2010. In the event we draw on our revolving credit facility and/or interest rates change significantly, we anticipate that we would take actions intended to further mitigate our exposure to such change by targeting a portion of our debt portfolio to be maintained at fixed rates and periodically entering into interest rate swap agreements. Information on quantitative and qualitative disclosure about market risk is included in Part I, Item 2 of this Quarterly Report on Form

25

10-Q under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources.”

Item 4. Controls and Procedures.

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

     We carried out an evaluation, under the supervision and with the participation of management, including our Chief Executive Officer and Chief Accounting Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report pursuant to Securities Exchange Act Rule 13a-15. Based upon that evaluation, our Chief Executive Officer and Chief Accounting Officer concluded that our disclosure controls and procedures were effective in ensuring that information required to be disclosed by us (including our consolidated subsidiaries) in reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported on a timely basis.

Changes in Internal Control Over Financial Reporting

     There has been no change in our internal control over financial reporting during the quarter ended September 30, 2010 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

     We are, from time to time, subject to various claims and legal actions that arise in the ordinary course of our business, including claims for damages for personal injuries, medical malpractice, breach of contract, business tort and employment related claims. In these actions, plaintiffs request a variety of damages, including, in some instances, punitive and other types of damages that may not be covered by insurance.

     A stockholder lawsuit and a stockholder derivative lawsuit alleging violations of federal securities laws were filed in 2009 against us and certain of our executives. We believe the lawsuits are without merit and are defending them vigorously. The stockholder derivative lawsuit will be extinguished by the closing of the Merger.

     In the opinion of management, we are not currently a party to any proceeding that would have a material adverse effect on our business, financial condition or results of operations.

Litigation Related to the Merger

     Seven putative class action complaints were filed on behalf of alleged public stockholders of the Company. Two of the lawsuits, Carpenters Pension Fund of West Virginia v. Psychiatric Solutions, Inc., et al., Case No. 38359, and Pedric v. Psychiatric Solutions, Inc., et al., Case No. 38391, were filed in the Chancery Court for Williamson County, Tennessee. One of the lawsuits, Smith v. Psychiatric Solutions, Inc., et al., Case No. 10-862-II, was filed in the Chancery Court for Davidson County, Tennessee. The Smith case was transferred to Williamson County. Another three lawsuits, Oklahoma Police Pension and Retirement System v. Jacobs, et al., Case No. CA 5514, City of Miami Police Relief and Pension Fund v. Jacobs, et al., Case No. 5515, and Plumbers & Pipefitters, Local 152 Pension Fund v. Psychiatric Solutions, Inc., et al., Case No. 5532, were filed in the Court of Chancery for the State of Delaware. A seventh lawsuit, Rosinek v. Psychiatric Solutions, Inc., et al., Case No. 3:10-cv-00534, was filed in the United States District Court for the Middle District of Tennessee. The defendants generally include us, members of our board of directors and, in certain of the cases, our officers. UHS and/or its affiliates are named as defendants in some of the lawsuits. The lawsuits allege, among other things, that our directors breached their fiduciary duties in connection with the proposed Merger by failing to maximize stockholder value. The lawsuits also allege that our directors have put their personal interests ahead of those of our stockholders, including by approving the Merger to extinguish any personal liability they could suffer from previously asserted derivative claims related to, among other things, violations of fiduciary duties and federal securities laws and also by negotiating a Merger Agreement that includes broad director and officer insurance and indemnification provisions protecting them against civil and criminal claims for six years from the date of the Merger Agreement. Certain of the lawsuits allege that various individual defendants will receive improper change of control payments and Merger Consideration in connection with equity awards that plaintiffs contend were improper. Certain of the lawsuits also allege that we and UHS aided and abetted the various breaches of fiduciary duty. Certain of the lawsuits also allege that various individual defendants caused us to issue a proxy statement containing materially false and misleading statements and omissions in connection with our 2010 annual stockholder meeting. Among other things, the lawsuits seek to enjoin us and our directors from consummating the Merger and also seek rescission of the allegedly improper equity awards. The three Delaware cases were consolidated and set for trial beginning on August 5, 2010. The three Tennessee state court cases were consolidated in Williamson County, and then stayed in favor of the consolidated Delaware action by agreed order of the Williamson County court.

     After substantially completing fact discovery in the consolidated Delaware action, without admitting liability on the part of any of the defendants, the parties to the consolidated Delaware action and the consolidated Tennessee state court action have agreed in principle to terms of settlement as follows: (1) requiring additional disclosures in the proxy statement delivered to stockholders in connection with the Special Meeting called to vote on the Merger regarding, among other things, the background of and negotiations relating to the Merger, the Executive Performance Incentive Plan, the amendment to our 2009 Long-Term Equity Compensation Plan and adoption of the 2010 Long-Term Equity Compensation Plan, the circumstances surrounding our compensation

26

committee’s approval of equity and restricted stock grants in February 2010, and the financial disclosures relating to the transaction, including the discounted cash flow and other analyses performed by Goldman Sachs & Co.; (2) allowing our stockholders to revote on the proposal to amend the Equity Incentive Plan to increase the number of shares of Common Stock subject to grant under the Equity Incentive Plan by 900,000 and to restrict the repricing of options, originally approved by our stockholders at our annual meeting of stockholders in May 2010, and which revote was held on October 5, 2010, with stockholders again approving the amendment to the Equity Incentive Plan; (3) requiring the release by the class of stockholders entitled to vote on the Merger of any and all claims that have been or could have been made against any of the defendants relating to the Merger, the disclosures made by or on behalf of us through and including consummation of the Merger, and the compensation received by any defendant through and including the consummation of the Merger; and (4) requiring us to pay plaintiffs’ reasonable attorneys’ fees and expenses in the amounts ordered by the courts. The settlements in those actions are subject to court approval, which has not yet been obtained.

     The parties to the Rosinek case have agreed in principal to settle that case on terms identical to the proposed settlement in the consolidated cases, with the additional promise from the Rosinek plaintiff that she will participate in and not object to the class certification necessary in the consolidated cases for the court to approve the settlement. The United States District Court in has stayed the Rosinek case in light of the parties proposed settlement and in favor of the settlement approval proceedings in the consolidated cases.

     The settlements in the consolidated and Rosinek cases will not affect the form or amount of the consideration to be received by our stockholders in the Merger. The defendants have denied and continue to deny any wrongdoing or liability with respect to all claims, events, and transactions complained of in the aforementioned lawsuits or that they have engaged in any wrongdoing. The defendants have entered into the settlements to eliminate the uncertainty, burden, risk, expense and distraction of further litigation.

Item 1A. Risk Factors.

     There have been no material changes to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2009 and Quarterly Reports on Forms 10-Q for the quarters ended March 31, 2010 and June 30, 2010.

Item 6. Exhibits.

Exhibit
Number	Description
2.1	Agreement and Plan of Merger, dated May 16, 2010, by and among Psychiatric Solutions, Inc., Universal Health Services, Inc. and Olympus Acquisition Corp. (incorporated by reference to Exhibit 2 to the Company’s Current Report on Form 8-K, filed on May 17, 2010).
3.1	Amended and Restated Certificate of Incorporation of PMR Corporation, filed with the Delaware Secretary of State on March 9, 1998 (incorporated by reference to Exhibit 3.1 to the Company’s Annual Report on Form 10-K for the fiscal year ended April 30, 1998).
3.2	Certificate of Amendment to Amended and Restated Certificate of Incorporation of PMR Corporation, filed with the Delaware Secretary of State on August 5, 2002 (incorporated by reference to Exhibit 3.2 to the Company’s Quarterly Report on Form 10-Q for the quarter ended July 31, 2002).
3.3	Certificate of Amendment to Amended and Restated Certificate of Incorporation of Psychiatric Solutions, Inc., filed with the Delaware Secretary of State on March 21, 2003 (incorporated by reference to Appendix A to the Company’s Definitive Proxy Statement, filed on January 22, 2003).
3.4	Certificate of Amendment to Amended and Restated Certificate of Incorporation of Psychiatric Solutions, Inc., filed with the Delaware Secretary of State on December 15, 2005 (incorporated by reference to Exhibit 3.4 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2005).
3.5	By-laws (incorporated by reference to Exhibit 3 to the Company’s Current Report on Form 8-K, filed on November 6, 2007).

27

Exhibit
Number	Description
31.1*	Certification of the Chief Executive Officer of Psychiatric Solutions, Inc. pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of the Chief Accounting Officer of Psychiatric Solutions, Inc. pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*	Certifications of the Chief Executive Officer and Chief Accounting Officer of Psychiatric Solutions, Inc. pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101. INS**	XBRL Instance Document.
101. SCH**	XBRL Taxonomy Extension Schema Document.
101. CAL**	XBRL Taxonomy Calculation Linkbase Document.
101. LAB**	XBRL Taxonomy Labels Linkbase Document.
101. PRE**	XBRL Taxonomy Presentation Linkbase Document.

*	Filed or furnished herewith
**	Furnished electronically herewith

28

Signatures

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Psychiatric Solutions, Inc.
By:	/s/ Jack E. Polson
	Jack E. Polson
	Executive Vice President, Chief Accounting Officer

Dated: November 9, 2010

EX-31.1

EXHIBIT 31.1

CERTIFICATIONS

I, Joey A. Jacobs, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Psychiatric Solutions, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

     a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

     b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles;

     c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

     d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

     a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

     b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 9, 2010	/s/ Joey A. Jacobs
	Joey A. Jacobs
	Chairman, Chief Executive Officer and President

EX-31.2

EXHIBIT 31.2

CERTIFICATIONS

I, Jack E. Polson, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Psychiatric Solutions, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

     a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

     b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles;

     c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

     d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

     a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

     b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 9, 2010	/s/ Jack E. Polson
	Jack E. Polson
	Executive Vice President, Chief Accounting Officer

EX-32.1

EXHIBIT 32.1

PSYCHIATRIC SOLUTIONS, INC.
CERTIFICATIONS PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly Report of Psychiatric Solutions, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Joey A. Jacobs, Chairman, Chief Executive Officer and President of the Company, and I, Jack E. Polson, Executive Vice President, Chief Accounting Officer of the Company, each certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

     (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

     (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

     A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

Date: November 9, 2010

/s/ Joey A. Jacobs  

Joey A. Jacobs 

Chairman, Chief Executive Officer and President 

/s/ Jack E. Polson  

Jack E. Polson 

Executive Vice President, Chief Accounting Officer